Table 1 Demographic and clinical characteristics of newborns of SARS-CoV-2 positive mothers.
Characteristics | Patients/Value (N = 45) |
|---|---|
Maternal characteristics | |
 Age, median (IQR), years | 30 (27.5–35.5) |
 Vaginal delivery, no. (%) | 30 (66.7) |
 Cesarean section, no. (%) | 15 (33.3) |
 Length of stay, median (IQR), days | 3 (2–3) |
 Asymptomatic, no. (%) | 27 (60) |
 Symptomatic, no. (%) | 18 (40) |
 Symptoms, no. (%) | |
  Fever | 15 (33.3) |
  Cough | 16 (35.6) |
  Sore throat | 4 (8.9) |
  Shortness of breath | 6 (13.3) |
 Intensive care unit admission, no. (%) | 2 (4.4) |
 Mothers needing intubation, no. | 0 |
 Treatment with medications for COVID-19, no. (%) |  |
  Hydroxychloroquine | 6 (13.3) |
  Azithromycin | 5 (11.1) |
  Tocilizumab | 1 (2.2) |
Newborn characteristics | |
 Birth weight, mean (±SD), g | 3133 (±556) |
 Sex, no. (%) | |
  Female | 19 (42.2) |
  Male | 26 (47.8) |
 Gestational age, mean (range), weeks | 34 (30 5/7–41) |
 Term (>37 weeks), no. (%) | 41 (91.1) |
 Preterm (<37 weeks), no (%) | 4 (8.9) |
 APGAR at 1 min, median | 9 |
 APGAR at 5 min, median | 9 |
 NICU admission, no. (%) | 7 (15.6) |
  Prematurity | 3/7 (42.8) |
  Suspected sepsis | 4/7 (57.2) |
 Isolation during initial practice, no. (%) | 5 (11.1) |
 Breastfeeding and colocation, no. (%) | |
  Roomed-in | 33 (73.3) |
  Breastfeeding | 31/33 (94) |
  Received any breastmilk | 40 (88.9) |
 Nasopharyngeal PCR positive for SARS-CoV-2, no. (%) | 3 (6.7) |
 Newborn with symptoms of COVID-19, no. | 0 |
 Discharge disposition, no. (%) | |
  Discharge to the same household | 40/43 (93.0) |
  Discharge to different household | 3 (7.0) |
 Adherence to in-person newborn visit, no. (%) | 39/43 (90.6) |
 Symptomatic on in-person newborn visit, no. | 0 |
Adherence to televisit, no. (%) | 43/43 (100) |
Symptomatic on televisit, no. | 0 |